Barry Investment Advisors’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$710K Hold
171,894
0.15% 47
2026
Q1
$621K Hold
171,894
0.14% 55
2025
Q4
$586K Hold
171,894
0.13% 56
2025
Q3
$1.17M Hold
171,894
0.27% 48
2025
Q2
$2.34M Sell
171,894
-6,475
-4% -$61.1K 0.58% 34
2025
Q1
$970K Hold
178,369
0.26% 51
2024
Q4
$883K Hold
178,369
0.28% 49
2024
Q3
$935K Hold
178,369
0.29% 49
2024
Q2
$1.22M Hold
178,369
0.41% 42
2024
Q1
$1.83M Hold
178,369
0.61% 33
2023
Q4
$1.48M Hold
178,369
0.5% 37
2023
Q3
$1.11M Hold
178,369
0.4% 44
2023
Q2
$776K Hold
178,369
0.26% 58
2023
Q1
$303K Sell
178,369
-100
-0.1% -$177 0.1% 92
2022
Q4
$346K Hold
178,469
0.11% 87
2022
Q3
$352K Hold
178,469
0.12% 82
2022
Q2
$364K Hold
178,469
0.11% 90
2022
Q1
$630K Hold
178,469
0.17% 71
2021
Q4
$691K Hold
178,469
0.18% 64
2021
Q3
$1.11M Hold
178,469
0.31% 46
2021
Q2
$2.1M Hold
178,469
0.56% 35
2021
Q1
$2.82M Buy
178,469
+95,269
+115% +$1.71M 0.78% 33
2020
Q4
$543K Buy
+83,200
New +$610K 0.16% 59

Other funds holding LFMD

Barry Investment Advisors's LFMD Position: Q2 2026 in Review

Barry Investment Advisors held its LifeMD (LFMD) position steady in Q2 2026 at 171,894 shares worth $710K. The position accounts for 0.15% of the portfolio, ranked #47.

Barry Investment Advisors first reported a position in LFMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.82M in Q1 2021. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Barry Investment Advisors held 171,894 shares of LifeMD worth $710K as of Q2 2026.
  • Barry Investment Advisors left its LifeMD share count unchanged in Q2 2026.
  • LifeMD made up 0.15% of Barry Investment Advisors's portfolio in Q2 2026, its #47 holding.
  • Barry Investment Advisors first reported a position in LifeMD in Q4 2020 and has held it in 23 quarters since.
  • Barry Investment Advisors's LifeMD position peaked at $2.82M in Q1 2021.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Barry Investment Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.